000			01520 a2200445 4500
005			20250516122957.0
264		0	_c20130124
008			201301s 0 0 ger d
022			_a1439-4413
024	7		_a10.1055/s-0032-1327270 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchmid-Wendtner, M
245	0	0	_a[Malignant melanoma]. _h[electronic resource]
260			_bDeutsche medizinische Wochenschrift (1946) _cDec 2012
300			_a2548-50 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aCombined Modality Therapy
650	0	4	_aDiagnostic Imaging
650	0	4	_aDisease Progression
650	0	4	_aDisease-Free Survival
650	0	4	_aEarly Diagnosis
650	0	4	_aHumans
650	0	4	_aIndoles _xadverse effects
650	0	4	_aIpilimumab
650	0	4	_aLymphatic Metastasis _xpathology
650	0	4	_aMelanoma _xdiagnosis
650	0	4	_aMitotic Index
650	0	4	_aNeoplasm Invasiveness
650	0	4	_aNeoplasm Recurrence, Local _xprevention & control
650	0	4	_aNeoplasm Staging
650	0	4	_aSkin _xpathology
650	0	4	_aSkin Neoplasms _xdiagnosis
650	0	4	_aSulfonamides _xadverse effects
650	0	4	_aVemurafenib
700	1		_aWendtner, C-M
773	0		_tDeutsche medizinische Wochenschrift (1946) _gvol. 137 _gno. 49 _gp. 2548-50
856	4	0	_uhttps://doi.org/10.1055/s-0032-1327270 _zAvailable from publisher's website
999			_c22298405 _d22298405